3,3,4,4-Tetramethylazetidin-2-one

CAS: 13423-22-8

Ref. 3D-NAA42322

Produktinformation

• Name: 3,3,4,4-Tetramethylazetidin-2-one
• Marke: Biosynth
• Beschreibung: 3,3,4,4-Tetramethylazetidin-2-one is a drug that has been shown to be effective for the treatment of cancer in animal models and human patients. It inhibits the growth of tumor cells by inhibiting DNA synthesis and causing cell death through apoptosis. 3,3,4,4-Tetramethylazetidin-2-one has also been shown to have cardiotoxic effects in animals and humans when administered orally. 3,3,4,4-Tetramethylazetidin-2-one binds to plasma proteins that are found in high concentrations in the heart muscle. This binding may lead to a decrease in cardiac output and an increase in blood pressure. 3,3,4,4-Tetramethylazetidin-2-one is not absorbed into the bloodstream following oral administration and does not accumulate in tissues or organs. The drug is eliminated primarily through the kidneys with a

Chemische Eigenschaften

• Molekulargewicht: 127.18 g/mol
• Formel: C₇H₁₃NO
• Reinheit: Min. 95%